Injectable preserving medium for preserving cells from placental blood, from bone marrow and from peripheral blood

A technology for placental blood and peripheral blood, applied in the medical field, can solve problems such as long-term processing operations

Active Publication Date: 2018-06-08
ESTAB FR DU SANG +2
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Washing requires a relatively long handling operation which requires specialized equipment and personnel

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Injectable preserving medium for preserving cells from placental blood, from bone marrow and from peripheral blood
  • Injectable preserving medium for preserving cells from placental blood, from bone marrow and from peripheral blood
  • Injectable preserving medium for preserving cells from placental blood, from bone marrow and from peripheral blood

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020] Therefore, the present invention relates to a solution for preserving cells from placental blood, from bone marrow and from peripheral blood, which preservation solution is injectable. Cells from placental blood, bone marrow and peripheral blood can be native (post-harvest), thawed or expanded ex vivo. "Injectable solution for preserving cells from placental blood, from bone marrow and from peripheral blood" means that said solution is adapted for injection and adapted for preserving said cells.

[0021] In this application, "injectable" means that the preservation solution is adapted for injection (eg intravenous, intramuscular, subcutaneous, etc...) into the human body without prior flushing of the cells. Therefore, the solution contains only ingredients approved by an authority regulating drug safety, such as the FDA (Food and Drug Administration), the European Medicines Agency (EMA) or the French National Agency for the Safety of Medicines and Healthcare products (A...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a solution for preserving cells from placental blood, from bone marrow and from peripheral blood, said solution being injectable.

Description

technical field [0001] The present invention relates to the field of medicine, and in particular to culture media for preserving cells from placental blood, from bone marrow and from peripheral blood. Background technique [0002] Placental blood stem cells are an alternative to bone marrow transplantation. Therefore, patients without a related or compatible donor on the National Marrow Donor Registry may benefit from transplantation of one or two units of placental blood. The advantage of this surrogate is that these cells avoid the need for a very high level of HLA compatibility between the patient and the transplanted cells. [0003] Between the steps of collecting placental blood units and freezing them, currently implemented recommendations specify only a 24-hour period because the viability and functionality of stem and progenitor cells are reduced at 4°C. Extending this time period would allow placental blood units to be collected on weekends and also increase the d...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A01N1/02
CPCA01N1/0226A01N1/02A01N1/0263
Inventor 佐兰·伊万诺维奇让·舍瓦莱尔劳拉·罗德里格斯埃斯泰·阿特比
Owner ESTAB FR DU SANG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products